A meta-analysis attempts to clear the uncertainty around this tomato-based nutrient.
Updating the story for lycopene and blood pressure, Chinese researchers have completed the latest meta-analysis on this tomato compound and its blood pressure effects.
Writing in the journal Nutrients, they compiled the results of six studies that met inclusion criteria-studies ranged from 4 to 16 weeks in duration, using 4.5 to 15 mg of daily lycopene with healthy or hypertensive participants.
Considering all of the available data, lycopene use significantly lowered systolic blood pressure-but not diastolic blood pressure-and effects were most prominent in Asians and subjects who already had high blood pressure to begin with. A dosage of at least 12 mg yielded the best results.
Manufacturers likely prefer natural ingredients that can lower both dystolic and diastolic blood pressure, but, considering the side effects associated with hypertensive drugs and the limited availability of natural alternatives, lycopene may still be useful.
It’s worth noting that four of the six studies used Lyc-O-Mato lycopene from Lycored Ltd. (Beer Sheva, Israel).
Meta-analysis does not find increased risk of bleeding events from omega-3 PUFA consumption
July 8th 2024Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.
Recent review states that pentadecanoic acid may support cellular stability for better longevity
June 25th 2024According to the paper’s author, Stephanie Venn-Watson, DVM, MPH, deficiency in pentadecanoic acid of ≤0.2% total circulating fatty acids increases the risk of ferroptosis, which a type of cell death cause by the peroxidation of fragile fatty acids in cell membranes that combines with iron thus increasing reactive oxygen species, and disabling mitochondria.
Recent review makes the case for testing omega-3 fatty acid levels in humans
May 23rd 2024The article commissioned by The Global Organization for EPA and DHA Omega-3s (GOED) reviewed the state of omega-3 fatty acid testing, highlighting the value of testing and the commercially available options for diagnostic testing.
Epax launches concentrated oil that combines omegas 3, 9, and 11
May 10th 2024The blend of long-chain polyunsaturated fatty acids and long-chain monounsaturated fatty acids combines the heart and brain health benefits of omegas-3s with the skin and metabolic health benefits of omegas 9 and 11.